Nonimmune hydrops fetalis: Fetal and neonatal outcome during 1983-1992

Leontien S. Wafelman, Bradley H Pollock, Jacqueline Kreutzer, Douglas S. Richards, Alastair A. Hutchison

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Prognostic factors for survival of 62 fetuses and neonates with nonimmune hydrops fetalis (NIHF) were studied retrospectively. Twenty-eight infants survived ≥ 28 days which is 45% for all fetuses and newborns diagnosed with NIHF and 61% for liveborns with unresolved NIHF. Univariate analysis identified that mortality was associated with the presence of ≥ 2 serous cavity effusions and a need for chest compressions at birth. Multivariate logistic regression analysis confirmed that the presence of ≥ 2 serous cavity effusions was significantly associated with mortality from NIHF < 28 days after birth [OR = 48.2 (CI 3.6, 662.9) (p < 0.004)]. We conclude that, compared to published cases from the 1970s and early 1980s, survival of liveborns with NIHF seems improved. The decrease in stillbirths is more notable. The severity of hydrops at birth is the key determinant for survival.

Original languageEnglish (US)
Pages (from-to)73-81
Number of pages9
JournalBiology of the Neonate
Volume75
Issue number2
DOIs
StatePublished - Feb 1999
Externally publishedYes

Fingerprint

Hydrops Fetalis
Parturition
Fetus
Newborn Infant
Stillbirth
Mortality
Edema
Thorax
Logistic Models
Regression Analysis

Keywords

  • Fetal outcome, hydrops
  • Fetal therapy
  • Multivariate logistic regression analysis
  • Neonatal outcome, hydrops
  • Nonimmune fetal hydrops
  • Prognostic factors

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health

Cite this

Nonimmune hydrops fetalis : Fetal and neonatal outcome during 1983-1992. / Wafelman, Leontien S.; Pollock, Bradley H; Kreutzer, Jacqueline; Richards, Douglas S.; Hutchison, Alastair A.

In: Biology of the Neonate, Vol. 75, No. 2, 02.1999, p. 73-81.

Research output: Contribution to journalArticle

Wafelman, LS, Pollock, BH, Kreutzer, J, Richards, DS & Hutchison, AA 1999, 'Nonimmune hydrops fetalis: Fetal and neonatal outcome during 1983-1992', Biology of the Neonate, vol. 75, no. 2, pp. 73-81. https://doi.org/10.1159/000014080
Wafelman, Leontien S. ; Pollock, Bradley H ; Kreutzer, Jacqueline ; Richards, Douglas S. ; Hutchison, Alastair A. / Nonimmune hydrops fetalis : Fetal and neonatal outcome during 1983-1992. In: Biology of the Neonate. 1999 ; Vol. 75, No. 2. pp. 73-81.
@article{a3a2a517aeef41c49194d0f9a39c3a5f,
title = "Nonimmune hydrops fetalis: Fetal and neonatal outcome during 1983-1992",
abstract = "Prognostic factors for survival of 62 fetuses and neonates with nonimmune hydrops fetalis (NIHF) were studied retrospectively. Twenty-eight infants survived ≥ 28 days which is 45{\%} for all fetuses and newborns diagnosed with NIHF and 61{\%} for liveborns with unresolved NIHF. Univariate analysis identified that mortality was associated with the presence of ≥ 2 serous cavity effusions and a need for chest compressions at birth. Multivariate logistic regression analysis confirmed that the presence of ≥ 2 serous cavity effusions was significantly associated with mortality from NIHF < 28 days after birth [OR = 48.2 (CI 3.6, 662.9) (p < 0.004)]. We conclude that, compared to published cases from the 1970s and early 1980s, survival of liveborns with NIHF seems improved. The decrease in stillbirths is more notable. The severity of hydrops at birth is the key determinant for survival.",
keywords = "Fetal outcome, hydrops, Fetal therapy, Multivariate logistic regression analysis, Neonatal outcome, hydrops, Nonimmune fetal hydrops, Prognostic factors",
author = "Wafelman, {Leontien S.} and Pollock, {Bradley H} and Jacqueline Kreutzer and Richards, {Douglas S.} and Hutchison, {Alastair A.}",
year = "1999",
month = "2",
doi = "10.1159/000014080",
language = "English (US)",
volume = "75",
pages = "73--81",
journal = "Neonatology",
issn = "1661-7800",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Nonimmune hydrops fetalis

T2 - Fetal and neonatal outcome during 1983-1992

AU - Wafelman, Leontien S.

AU - Pollock, Bradley H

AU - Kreutzer, Jacqueline

AU - Richards, Douglas S.

AU - Hutchison, Alastair A.

PY - 1999/2

Y1 - 1999/2

N2 - Prognostic factors for survival of 62 fetuses and neonates with nonimmune hydrops fetalis (NIHF) were studied retrospectively. Twenty-eight infants survived ≥ 28 days which is 45% for all fetuses and newborns diagnosed with NIHF and 61% for liveborns with unresolved NIHF. Univariate analysis identified that mortality was associated with the presence of ≥ 2 serous cavity effusions and a need for chest compressions at birth. Multivariate logistic regression analysis confirmed that the presence of ≥ 2 serous cavity effusions was significantly associated with mortality from NIHF < 28 days after birth [OR = 48.2 (CI 3.6, 662.9) (p < 0.004)]. We conclude that, compared to published cases from the 1970s and early 1980s, survival of liveborns with NIHF seems improved. The decrease in stillbirths is more notable. The severity of hydrops at birth is the key determinant for survival.

AB - Prognostic factors for survival of 62 fetuses and neonates with nonimmune hydrops fetalis (NIHF) were studied retrospectively. Twenty-eight infants survived ≥ 28 days which is 45% for all fetuses and newborns diagnosed with NIHF and 61% for liveborns with unresolved NIHF. Univariate analysis identified that mortality was associated with the presence of ≥ 2 serous cavity effusions and a need for chest compressions at birth. Multivariate logistic regression analysis confirmed that the presence of ≥ 2 serous cavity effusions was significantly associated with mortality from NIHF < 28 days after birth [OR = 48.2 (CI 3.6, 662.9) (p < 0.004)]. We conclude that, compared to published cases from the 1970s and early 1980s, survival of liveborns with NIHF seems improved. The decrease in stillbirths is more notable. The severity of hydrops at birth is the key determinant for survival.

KW - Fetal outcome, hydrops

KW - Fetal therapy

KW - Multivariate logistic regression analysis

KW - Neonatal outcome, hydrops

KW - Nonimmune fetal hydrops

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=0032944717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032944717&partnerID=8YFLogxK

U2 - 10.1159/000014080

DO - 10.1159/000014080

M3 - Article

C2 - 9852356

AN - SCOPUS:0032944717

VL - 75

SP - 73

EP - 81

JO - Neonatology

JF - Neonatology

SN - 1661-7800

IS - 2

ER -